Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines. - Wikidata - awgldk - TriplyDB

Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines.

Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines.

http://www.wikidata.org/entity/Q30360768

about

Induction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine.A life without worms.Enhanced humoral response to influenza vaccine in aged mice with a novel adjuvant, rOv-ASP-1.

P2860

Q30382453-C914B2A1-F6AA-4281-81E6-B7C0AF4B5AFB Q33623662-BB0238B2-67E2-4621-A8CE-DE6B29477516 Q40822873-466D8A6C-A22D-42A8-AE17-69E19ADF5643

P2860

Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines.

http://www.wikidata.org/entity/Q30360768

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Antigen sparing and enhanced p ...... ation with influenza vaccines.

@ast

Antigen sparing and enhanced p ...... ation with influenza vaccines.

@en

type

label

Antigen sparing and enhanced p ...... ation with influenza vaccines.

@ast

Antigen sparing and enhanced p ...... ation with influenza vaccines.

@en

prefLabel

Antigen sparing and enhanced p ...... ation with influenza vaccines.

@ast

Antigen sparing and enhanced p ...... ation with influenza vaccines.

@en

P1433

Q30360768-4DFC0D70-AA83-4ECF-A545-895C5CB924EB

P1476

Q30360768-CB29B590-F518-4A21-8C3F-5B81E07CC345

P2093

Q30360768-18299C15-E801-4DBB-98DC-906FCF006E98

Q30360768-3DE875CC-A9C1-4C8B-9302-BB62A57C8ABC

Q30360768-803DA11C-FF15-4CDB-8A8D-E2C148C0A0B2

Q30360768-B0397783-F0FA-42C1-89EB-F2E7CC87AB5D

Q30360768-BB170067-20D8-4F56-90CC-DB12A046D979

P2860

Q30360768-007CFAC2-2AD6-496F-81E4-231ED3763EE4

Q30360768-0A707798-98E8-46C6-B529-06F9C4B7897D

Q30360768-0E0F39EE-5CC9-4833-BE45-479BA3902954

Q30360768-1A590612-7FBD-40B9-95EA-1F7AFD889CB0

Q30360768-1AEFD9DD-1B44-4937-B5C2-F101BBDC32A1

Q30360768-2BB8A828-3502-469E-96A2-244F55EC16C6

Q30360768-2BCFABDA-69C9-481A-9A91-A778FBF4D0A9

Q30360768-31C97672-BF8D-4A97-AD34-BFECC561A01F

Q30360768-3CD27FB7-4848-4341-9A33-7CD7FCD0D1D3

Q30360768-4468712F-E8BF-4196-8024-6310FCA0CCC6

P304

Q30360768-4C3EA431-6E1E-414F-8EA9-184E945636F7

P31

Q30360768-0A5E1DDD-CCD5-40FB-96CD-7E720C0FFC86

P356

Q30360768-421EBF64-9F09-496B-BD6E-C3CCD0F87598

P407

Q30360768-29545D83-B170-4B0A-B0E2-3874C6BC0A45

P433

Q30360768-4472AE34-389D-43A6-9A21-516E65B619AF

P478

Q30360768-896F7B52-B4AC-438F-BC36-7CAEA5C94CCA

P50

Q30360768-F9FCC580-E8FF-45F6-9272-0C122C9F9795

P577

Q30360768-FFB39B64-201D-4C4C-9AD1-953B53F0983A

P698

Q30360768-73675FEB-C42A-48D7-90D7-0210864FA1D6

P932

Q30360768-69997DCB-39AA-4F37-8066-77DA0BB7968C

P356

J.VACCINE.2014.03.046

P1433

P1476

Antigen sparing and enhanced p ...... ation with influenza vaccines.

@en

P2093

Donna M Murasko

http://www.w3.org/2001/XMLSchema#string

Erin M Fisher

http://www.w3.org/2001/XMLSchema#string

Hao Shen

http://www.w3.org/2001/XMLSchema#string

Jiu Jiang

http://www.w3.org/2001/XMLSchema#string

Scott E Hensley

http://www.w3.org/2001/XMLSchema#string

P2860

The adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primates

Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.

Adaptation of pandemic H1N1 influenza viruses in mice.

An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers.

MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines.

Influenza nucleoprotein delivered with aluminium salts protects mice from an influenza A virus that expresses an altered nucleoprotein sequence.

New directions in vaccine research.

Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence.

Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines.

How do adjuvants work? Important considerations for new generation adjuvants.

P304

2696-2702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2014.03.046

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24681229

http://www.w3.org/2001/XMLSchema#string

P932

4080630

http://www.w3.org/2001/XMLSchema#string